These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35174182)

  • 1. Publication Trends of Research on Polypoidal Choroidal Vasculopathy During 2001-2020: A 20-Year Bibliometric Study.
    Wang Y; Xie M; Zhang M; Zhao X; Zhu X; Wang Y; Chen Y; Chen J; Sun X
    Front Med (Lausanne); 2021; 8():785126. PubMed ID: 35174182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Kokame GT; deCarlo TE; Kaneko KN; Omizo JN; Lian R
    Ophthalmol Retina; 2019 Sep; 3(9):744-752. PubMed ID: 31511169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
    Kokame GT; Omizo JN; Kokame KA; Yamane ML
    Ophthalmol Retina; 2021 Oct; 5(10):954-961. PubMed ID: 34022443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy for polypoidal choroidal vasculopathy.
    Nowak-Sliwinska P; van den Bergh H; Sickenberg M; Koh AH
    Prog Retin Eye Res; 2013 Nov; 37():182-99. PubMed ID: 24140257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Age-related Macular Degeneration in the Japanese].
    Yoshimura N
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study.
    Ting DS; Ng WY; Ng SR; Tan SP; Yeo IY; Mathur R; Chan CM; Tan AC; Tan GS; Wong TY; Cheung CM
    Am J Ophthalmol; 2016 Apr; 164():128-36.e1. PubMed ID: 26743619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polypoidal choroidal vasculopathy].
    Yuzawa M
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):200-31; discussion 232. PubMed ID: 22568102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of Complete Polypoidal Regression after Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy.
    Chaikitmongkol V; Upaphong P; Patikulsila D; Jirarattanasopa P; Choovuthayakorn J; Watanachai N; Kunavisarut P; Ratanasukon M; Bhurayanontachai P; Ingviya T; Bressler SB; Bressler NM
    Ophthalmol Retina; 2022 Jan; 6(1):21-28. PubMed ID: 33781929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DETAILED CHARACTERIZATION OF CHOROIDAL MORPHOLOGIC AND VASCULAR FEATURES IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Gupta P; Ting DSW; Thakku SG; Wong TY; Cheng CY; Wong E; Mathur R; Wong D; Yeo I; Gemmy Cheung CM
    Retina; 2017 Dec; 37(12):2269-2280. PubMed ID: 28145972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Treatment Outcomes of Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Asians.
    Fenner BJ; Ting DSW; Tan ACS; Teo K; Chan CM; Mathur R; Yeo IYS; Wong TY; Wong EYM; Cheung CMG
    Ophthalmol Retina; 2020 Apr; 4(4):403-414. PubMed ID: 31953109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripapillary Choroidal Thickness Change of Polypoidal Choroidal Vasculopathy after Anti-vascular Endothelial Growth Factor.
    Lee KH; Kim SH; Lee JM; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Oct; 31(5):431-438. PubMed ID: 28994269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis.
    Díaz-Villamarín X; Blánquez-Martínez D; Pozo-Agundo A; Pérez-Gutiérrez AM; Muñoz-Ávila JI; Antúnez-Rodríguez A; Fernández-Gómez AE; García-Navas P; Martínez-González LJ; Dávila-Fajardo CL
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33198211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Vascular Endothelial Growth Factor Inhibitors and Complementary Treatment Options in Polypoidal Choroidal Vasculopathy: A Subtype of Neovascular Age-Related Macular Degeneration.
    Teo KYC; Gillies M; Fraser-Bell S
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30177632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypoidal choroidal vasculopathy: an update on therapeutic approaches.
    Wong RL; Lai TY
    J Ophthalmic Vis Res; 2013 Oct; 8(4):359-71. PubMed ID: 24653824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization.
    Tong JP; Chan WM; Liu DT; Lai TY; Choy KW; Pang CP; Lam DS
    Am J Ophthalmol; 2006 Mar; 141(3):456-62. PubMed ID: 16490490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management strategy of polypoidal choroidal vasculopathy.
    Ho CPS; Lai TYY
    Indian J Ophthalmol; 2018 Dec; 66(12):1727-1735. PubMed ID: 30451173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
    Chong Teo KY; Sadda SR; Gemmy Cheung CM; Chakravarthy U; Staurenghi G; Invernizzi A; Ogura Y; Ruamviboonsuk P; Chen SJ; Gupta V; Tan C; Chhablani J; Corvi F; Kim JE; Gomi F; Koh AH; Kokame G; Mitchell P; Wong TY; Lee WK; Lai TYY
    Ophthalmol Retina; 2021 Oct; 5(10):945-953. PubMed ID: 33866022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.